The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Seagen
Efficacy of tucatinib+trastuzumab+capecitabine (TTC) after trastuzumab-deruxtecan (T-DXd) exposure in Her2-positive metastatic breast cancer: A French multicentre retrospective study.
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca (Inst); Clovis Oncology (Inst); Daiichi Sankyo Europe GmbH (Inst); Eisai; Exact Sciences (Inst); Gilead Sciences; GlaxoSmithKline; Lilly; MSD Oncology (Inst); Novartis (Inst); Pfizer; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Gilead Sciences; Lilly; MSD Oncology; Novartis; Pfizer; seagen
 
Jean Zeghondy
No Relationships to Disclose
 
Catherine Guerin
No Relationships to Disclose
 
Audrey Mailliez
Consulting or Advisory Role - DAICHII SANKYO; PFIZER; SEAGEN
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pierre Fabre
 
Elsa Volant
No Relationships to Disclose
 
Francois Poumeaud
No Relationships to Disclose
 
Anne Patsouris
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Eisai; NOVARTIS; Pfizer; Roche
 
Monica Arnedos
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical (Inst); Gilead Sciences; Menarini; Novartis; Pfizer; Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; Lilly O.; Novartis; Pfizer
 
Caroline Bailleux
No Relationships to Disclose
 
Julie Cabal
No Relationships to Disclose
 
Loick Galland
No Relationships to Disclose
 
Alexandre De nonneville
Consulting or Advisory Role - Daiichi Sankyo Pharmaceutical; Gilead Sciences; Lilly O.; MSD; Novartis Biociencias; Pfizer; Seagen
Research Funding - Lilly O. (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; MSD; Novartis; Pfizer
 
Severine Guiu Lahaye
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Novartis; Novartis
 
Florence Dalenc
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo Pharmaceutical; Gilead Sciences; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Gilead Sciences; Pfizer
 
Barbara Pistilli
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Myriad Genetics; Novartis; PIERRE FABRE; Puma Biotechnology
Research Funding - AstraZeneca (Inst); DAIICHI-SANKYO (Inst); Gilead Sciences (Inst); Merus (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; MSD Oncology; Novartis; Pfizer; Pierre Fabre
 
Thomas Bachelot
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; pfizer; Roche
 
Pierre Martin
No Relationships to Disclose
 
Francois Bocquet
No Relationships to Disclose
 
Louis Larrouquere
No Relationships to Disclose
 
Delphine Loirat
Honoraria - AstraZeneca; Gilead Sciences; Gilead Sciences; Lilly; MSD
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Gilead Sciences; Immunomedics; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; MSD; Pfizer; Roche